Anthropic Inks 45 Billion SpaceX Agreement to Power Claude AI Infrastructure Reliance Targets Multifold FMCG Growth by 2030 Through Acquisitions and Global Expansion UK Exports to US Slide 25 Following Trumps Tariff Measures Turning Trade Surplus into Deficit Workday Shares Rise on Upgraded Margin Outlook Driven by AI Adoption White House and China Announce Trade Deals on Soybeans and Rare Earths Following TrumpXi Summit Andy Burnhams Manchester Vision A Model for Regional Economic Policy and Investment Potential Perspective Therapeutics Inc CATX Q1 2026 Earnings EPS Beat by 17 as PreRevenue Biotech Advances Radiopharmaceutical Pipeline FGI Industries Ltd FGI Q1 2026 Earnings Strong EPS Beat Amid Challenging Environment Arcturus Therapeutics Holdings Inc ARCT Q1 2026 Earnings Narrower Net Loss Beats Estimates Amid Pipeline Progress Redwood Trust Inc 900 Senior Notes Due 2029 RWTO Q1 2026 Earnings EPS Miss Weighs on Note Performance VELO Q1 2026 Earnings Narrowed Loss Exceeds Expectations Shares Rise 9 REXR Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency Virtus Global MultiSector Income Fund VGI Edges Higher Amid Balanced Trading Chunghwa Telecom CHT Holds Steady Near Support as Telecom Sector Faces Headwinds FactSet Research Systems FDS Gains 153 Approaches Key Resistance BJs Wholesale Club BJ Gains 26 as Retail Sector Finds Footing High Income Securities Fund PCF Holds Steady Near Support Amid Low Volatility Snowflake Surges After Earnings Beat and 6 Billion Amazon Cloud Deal WeRide Inc WRD Q1 2026 Earnings EPS Misses Estimates as Revenue Disappears Virtus AI Tech Opportunities Fund AIO Edges Higher Testing Resistance as Sector Sentiment Improves ALXO Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Evorpacept Development Alpine Income Property Trust Inc PINE Q1 2026 Earnings EPS Misses Analyst Expectations as Stock Advances HSDT Q1 2026 Earnings Significant EPS Miss Amid Challenging Quarter MGR Q1 2026 Earnings EPS Surpasses Estimates Stock Rises RXT Q1 2026 Earnings EPS Misses Estimates by a Wide Margin Shares Decline AMWL Q1 2026 Earnings Narrowed Loss Surpasses Expectations Shares Rise Milestone Pharmaceuticals MIST Q1 2026 Earnings Significant EPS Miss as PreRevenue Biotech Continues Pipeline Development